Metal complexes with superoxide dismutase-like activity as candidates for anti-prion drug

Various compounds were evaluated for ability to inhibit the formation of the abnormal protease-resistant form of prion protein (PrP-res) in two cell lines infected with different prion strains. Examination of the structure–activity relationships indicated that compounds with copper-selective chelating ability and whose copper complexes have high SOD-like activity are candidates for anti-prion drug.

The compounds whose metal complexes had high SOD-like activity, 2,2′-biquinoline, cimetidine, and TPEN, had values of 50%-inhibitory concentration for PrP-res formation (IC50) of <10 nM in ScN2a cells.Figure optionsDownload as PowerPoint slide